| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |